MARSHALL WACE, LLP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$379,474
-81.3%
6,333
-77.0%
0.00%
-75.0%
Q1 2023$2,029,005
-67.3%
27,583
-70.3%
0.00%
-71.4%
Q4 2022$6,203,249
+80.6%
92,863
+132.8%
0.01%
+75.0%
Q3 2022$3,434,000
-3.5%
39,8830.0%0.01%
+14.3%
Q2 2022$3,559,000
+191.0%
39,883
+354.5%
0.01%
+40.0%
Q3 2021$1,223,000
+91.7%
8,776
+36.8%
0.01%
+66.7%
Q4 2020$638,000
+72.9%
6,415
+26.3%
0.00%
-25.0%
Q1 2020$369,000
-89.3%
5,078
-83.2%
0.00%
-85.7%
Q2 2019$3,448,000
-75.6%
30,205
-73.1%
0.03%
-58.2%
Q1 2019$14,122,000
-32.7%
112,322
-27.3%
0.07%
-68.7%
Q4 2018$20,971,000
+3383.6%
154,535
+6956.4%
0.21%
+7033.3%
Q3 2018$602,000
-48.7%
2,190
-61.3%
0.00%
-83.3%
Q2 2018$1,173,000
-76.8%
5,662
-94.0%
0.02%
-73.1%
Q4 2014$5,062,000
-44.5%
95,128
-51.0%
0.07%
-49.2%
Q3 2014$9,125,000
+4224.6%
194,181
+5631.4%
0.13%
+4300.0%
Q2 2014$211,000
-93.4%
3,388
-92.8%
0.00%
-94.8%
Q1 2014$3,179,00047,2710.06%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
KNOTT DAVID M 1,249,766$58,726,504,00011.17%
BVF INC/IL 1,108,763$52,101,00010.82%
GROW Partners, LLC 132,500$6,226,0005.58%
CARDINAL CAPITAL MANAGEMENT LLC /CT 936,825$44,021,0002.73%
First Light Asset Management, LLC 76,366$3,588,0002.45%
Healthcare Value Capital, LLC 50,000$2,350,0002.27%
OBERWEIS ASSET MANAGEMENT INC/ 168,337$7,910,0002.17%
RK Capital 174,283$8,190,0001.67%
Nichols Asset Management LLC 133,368$6,267,0001.30%
ASHFORD CAPITAL MANAGEMENT INC 108,289$5,089,0001.09%
View complete list of LIGAND PHARMACEUTICALS INC shareholders